Drug Manufacturers - General
Stocks Ranked by
Market Capitalization
Drug Manufacturers - General Stocks at a Glance
Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.
There are 46 Drug Manufacturers - General industry stocks tracked by Wall St. Rank, worth a combined $4.38T.
The largest by market cap are Eli Lilly (LLY) at $1.2T, Johnson & Johnson (JNJ) at $643B and AbbVie (ABBV) at $501B.
Among institutional investors, Merck (MRK) drew the most net new fund positions in Q3 2026: 306 funds opened new positions, taking total fund holders up 95 (2.4%) quarter-over-quarter.
- Combined market cap: $4.38T across 46 stocks.
- Largest constituent: Eli Lilly (LLY), $1.2T market cap.
- Most net new fund positions in Q3 2026: Merck (MRK), +95 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.